Kewaunee Scientific (KEQU) Competitors

Kewaunee Scientific logo
$35.28 -1.78 (-4.80%)
Closing price 03:59 PM Eastern
Extended Trading
$33.00 -2.28 (-6.46%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

KEQU vs. PRE, LAB, MASS, SENS, and NAUT

Should you buy Kewaunee Scientific stock or one of its competitors? MarketBeat compares Kewaunee Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kewaunee Scientific include Prenetics Global (PRE), Standard BioTools (LAB), 908 Devices (MASS), Senseonics Holdings, Inc. Common Stock (SENS), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry.

How does Kewaunee Scientific compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Prenetics Global currently has a consensus price target of $31.75, indicating a potential upside of 59.39%. Given Prenetics Global's stronger consensus rating and higher probable upside, equities analysts plainly believe Prenetics Global is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Prenetics Global has a beta of 0.24, meaning that its stock price is 76% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

Kewaunee Scientific has a net margin of 3.85% compared to Prenetics Global's net margin of -62.45%. Kewaunee Scientific's return on equity of 18.09% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-62.45% -20.33% -15.42%
Kewaunee Scientific 3.85%18.09%6.71%

In the previous week, Prenetics Global and Prenetics Global both had 2 articles in the media. Prenetics Global's average media sentiment score of 0.23 beat Kewaunee Scientific's score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Prenetics Global
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has higher revenue and earnings than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39M3.64-$37.71M-$4.58N/A
Kewaunee Scientific$240.47M0.42$11.40M$3.729.48

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Kewaunee Scientific beats Prenetics Global on 10 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 26.8% of Standard BioTools shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Kewaunee Scientific had 1 more articles in the media than Standard BioTools. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for Standard BioTools. Standard BioTools' average media sentiment score of 0.94 beat Kewaunee Scientific's score of 0.00 indicating that Standard BioTools is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Standard BioTools
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Standard BioTools presently has a consensus target price of $1.35, suggesting a potential upside of 70.43%. Given Standard BioTools' higher probable upside, analysts plainly believe Standard BioTools is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Standard BioTools$85.33M3.62-$74.90M$0.203.96
Kewaunee Scientific$240.47M0.42$11.40M$3.729.48

Standard BioTools has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

Standard BioTools has a net margin of 73.46% compared to Kewaunee Scientific's net margin of 3.85%. Kewaunee Scientific's return on equity of 18.09% beat Standard BioTools' return on equity.

Company Net Margins Return on Equity Return on Assets
Standard BioTools73.46% -8.18% -6.43%
Kewaunee Scientific 3.85%18.09%6.71%

Summary

Kewaunee Scientific beats Standard BioTools on 8 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to 908 Devices?

908 Devices (NASDAQ:MASS) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

In the previous week, Kewaunee Scientific had 1 more articles in the media than 908 Devices. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for 908 Devices. Kewaunee Scientific's average media sentiment score of 0.00 beat 908 Devices' score of -0.71 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
908 Devices
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

908 Devices has higher earnings, but lower revenue than Kewaunee Scientific. 908 Devices is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
908 Devices$57.80M5.71$19.49M-$1.00N/A
Kewaunee Scientific$240.47M0.42$11.40M$3.729.48

88.1% of 908 Devices shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 28.2% of 908 Devices shares are held by insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

908 Devices has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

908 Devices presently has a consensus price target of $12.00, suggesting a potential upside of 37.46%. Given 908 Devices' higher possible upside, equities analysts clearly believe 908 Devices is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
908 Devices
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has a net margin of 3.85% compared to 908 Devices' net margin of -62.40%. Kewaunee Scientific's return on equity of 18.09% beat 908 Devices' return on equity.

Company Net Margins Return on Equity Return on Assets
908 Devices-62.40% -14.03% -10.40%
Kewaunee Scientific 3.85%18.09%6.71%

Summary

Kewaunee Scientific beats 908 Devices on 9 of the 15 factors compared between the two stocks.

How does Kewaunee Scientific compare to Senseonics Holdings, Inc. Common Stock?

Kewaunee Scientific (NASDAQ:KEQU) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment.

32.7% of Kewaunee Scientific shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 13.3% of Kewaunee Scientific shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Kewaunee Scientific has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kewaunee Scientific$240.47M0.42$11.40M$3.729.48
Senseonics Holdings, Inc. Common Stock$40.71M6.20-$69.11M-$2.00N/A

Kewaunee Scientific has a net margin of 3.85% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Kewaunee Scientific's return on equity of 18.09% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Kewaunee Scientific3.85% 18.09% 6.71%
Senseonics Holdings, Inc. Common Stock -213.87%-129.97%-67.14%

In the previous week, Kewaunee Scientific had 1 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for Senseonics Holdings, Inc. Common Stock. Kewaunee Scientific's average media sentiment score of 0.00 equaled Senseonics Holdings, Inc. Common Stock'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.00, suggesting a potential upside of 181.46%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67

Kewaunee Scientific has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

Summary

Kewaunee Scientific beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Kewaunee Scientific compare to Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ:NAUT) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Nautilus Biotechnology currently has a consensus price target of $4.00, indicating a potential upside of 71.67%. Given Nautilus Biotechnology's higher probable upside, research analysts clearly believe Nautilus Biotechnology is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nautilus Biotechnology
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Nautilus Biotechnology has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

In the previous week, Kewaunee Scientific had 1 more articles in the media than Nautilus Biotechnology. MarketBeat recorded 2 mentions for Kewaunee Scientific and 1 mentions for Nautilus Biotechnology. Nautilus Biotechnology's average media sentiment score of 0.00 equaled Kewaunee Scientific'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nautilus Biotechnology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has a net margin of 3.85% compared to Nautilus Biotechnology's net margin of 0.00%. Kewaunee Scientific's return on equity of 18.09% beat Nautilus Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nautilus BiotechnologyN/A -35.04% -29.16%
Kewaunee Scientific 3.85%18.09%6.71%

Kewaunee Scientific has higher revenue and earnings than Nautilus Biotechnology. Nautilus Biotechnology is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nautilus BiotechnologyN/AN/A-$59M-$0.46N/A
Kewaunee Scientific$240.47M0.42$11.40M$3.729.48

50.7% of Nautilus Biotechnology shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 41.1% of Nautilus Biotechnology shares are held by company insiders. Comparatively, 13.3% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Kewaunee Scientific beats Nautilus Biotechnology on 8 of the 13 factors compared between the two stocks.

Get Kewaunee Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for KEQU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KEQU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KEQU vs. The Competition

MetricKewaunee ScientificINSTRU IndustryComputer SectorNASDAQ Exchange
Market Cap$106.23M$1.46B$39.38B$12.39B
Dividend YieldN/A0.35%3.27%5.83%
P/E Ratio9.483.16169.9023.98
Price / Sales0.421.35624.85109.54
Price / Cash5.047.4448.5354.51
Price / Book1.523.029.586.50
Net Income$11.40M-$9.28M$1.07B$336.88M
7 Day Performance-5.92%-3.18%-1.41%-0.22%
1 Month Performance-11.73%-7.85%0.99%0.77%
1 Year Performance-4.42%-4.14%159.21%31.57%

Kewaunee Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KEQU
Kewaunee Scientific
0.6495 of 5 stars
$35.28
-4.8%
N/A+1.0%$106.23M$240.47M9.481,239
PRE
Prenetics Global
2.4548 of 5 stars
$20.51
-1.2%
$31.75
+54.8%
+122.8%$350.14M$92.39MN/A1
LAB
Standard BioTools
2.9421 of 5 stars
$0.83
-2.0%
$1.35
+62.3%
-26.3%$331.19M$85.33M4.16620
MASS
908 Devices
2.2684 of 5 stars
$8.64
+0.2%
$12.00
+38.9%
+18.0%$325.95M$56.20MN/A60
SENS
Senseonics Holdings, Inc. Common Stock
3.3192 of 5 stars
$7.23
-0.1%
$17.00
+135.1%
N/A$302.65M$35.26MN/A90

Related Companies and Tools


This page (NASDAQ:KEQU) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners